X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (60) 60
humans (51) 51
male (40) 40
female (35) 35
aged (34) 34
middle aged (27) 27
oncology (18) 18
patients (17) 17
respiratory system (16) 16
chemotherapy (15) 15
lung diseases (15) 15
aged, 80 and over (13) 13
medicine, general & internal (13) 13
metastasis (13) 13
pneumonia (13) 13
case report (12) 12
lung (12) 12
lung neoplasms - pathology (12) 12
care and treatment (11) 11
gefitinib (11) 11
prognosis (11) 11
retrospective studies (11) 11
biopsy (10) 10
brain metastases (10) 10
cancer (10) 10
lung cancer (10) 10
lung cancer, non-small cell (10) 10
adult (9) 9
erlotinib (9) 9
interstitial lung disease (9) 9
mutation (9) 9
pulmonary fibrosis (9) 9
adenocarcinoma (8) 8
non-small cell lung cancer (8) 8
research (8) 8
tomography, x-ray computed (8) 8
treatment outcome (8) 8
analysis (7) 7
diagnosis (7) 7
fibrosis (7) 7
lung neoplasms - drug therapy (7) 7
pathology (7) 7
pulmonary/respiratory (7) 7
research article (7) 7
respiratory tract diseases (7) 7
risk factors (7) 7
tumors (7) 7
bacterial pneumonia (6) 6
brain neoplasms - secondary (6) 6
health aspects (6) 6
safety (6) 6
adenocarcinoma - pathology (5) 5
adenocarcinoma of lung (5) 5
carboplatin (5) 5
disease (5) 5
efficacy (5) 5
internal medicine (5) 5
kaplan-meier estimate (5) 5
lung - pathology (5) 5
lung cancer, small cell (5) 5
lung neoplasms - complications (5) 5
lung neoplasms - genetics (5) 5
medical prognosis (5) 5
medical research (5) 5
medicine (5) 5
metastases (5) 5
mutations (5) 5
mycobacterium avium complex (5) 5
protein kinase inhibitors - therapeutic use (5) 5
tuberculosis (5) 5
tuberculosis, pulmonary - drug therapy (5) 5
tuberculosis, pulmonary - microbiology (5) 5
bevacizumab (4) 4
carcinoma (4) 4
carcinoma, non-small-cell lung - drug therapy (4) 4
cisplatin (4) 4
complications and side effects (4) 4
disease progression (4) 4
disease-free survival (4) 4
dna mutational analysis (4) 4
drug therapy, combination (4) 4
epidermal growth factor (4) 4
erbb receptors - genetics (4) 4
idiopathic pulmonary-fibrosis (4) 4
immunohistochemistry (4) 4
lesions (4) 4
lung - diagnostic imaging (4) 4
magnetic resonance imaging (4) 4
medical personnel (4) 4
medicine, experimental (4) 4
multidisciplinary sciences (4) 4
mycobacterium infections, nontuberculous - microbiology (4) 4
physicians (4) 4
receptor, epidermal growth factor - genetics (4) 4
respiratory agents (4) 4
scleroderma (4) 4
survival (4) 4
systemic sclerosis (4) 4
therapy (4) 4
adenocarcinoma - complications (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Internal Medicine, ISSN 0918-2918, 2019, Volume 58, Issue 7, pp. 973 - 978
We herein report three cases of refractory Mycobacterium avium complex (MAC) disease successfully treated surgically despite the MAC lesions being present... 
refractory | Mycobacterium avium complex | surgical resection | bilateral | bronchoscopy | Bronchoscopy | Refractory materials | Signs and symptoms | Lung | Lung diseases | Sputum | Smear | Lesions | Index Medicus | Case Report
Journal Article
Internal Medicine, ISSN 0918-2918, 2017, Volume 56, Issue 14, pp. 1867 - 1871
Journal Article
Journal Article
Pathology International, ISSN 1320-5463, 12/2017, Volume 67, Issue 12, pp. 602 - 609
Journal Article
Journal Article
Internal Medicine, ISSN 0918-2918, 2019, Volume 58, Issue 8, pp. 1127 - 1130
We herein report two cases of miliary lung metastases from genital carcinoma in uterine cervix and endometrium. Notably, these patients were unable to receive... 
cervix | corpus | uterus | large-cell neuroendocrine carcinoma | miliary lung metastases | GROWTH-FACTOR RECEPTOR | MEDICINE, GENERAL & INTERNAL | PAPILLARY THYROID-CARCINOMA | MUTATIONS | Medical personnel | Carcinoma | Physicians | Lung | Lung carcinoma | Metastasis | Cervix | Metastases | Chemotherapy | Uterus | Autopsy | Fatalities | Differential diagnosis | Diagnosis | Endometrium | Index Medicus | Case Report
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2016, Volume 11, Issue 8, pp. e0161908 - e0161908
Background Patients with idiopathic interstitial pneumonias sometimes have a few features of connective tissue disease (CTD) and yet do not fulfil the... 
DISTINCT ENTITY | AUTOIMMUNE FEATURES | RESOLUTION COMPUTED-TOMOGRAPHY | MULTIDISCIPLINARY SCIENCES | LUNG-DISEASE | LUPUS-ERYTHEMATOSUS | CONNECTIVE-TISSUE DISEASE | COLLAGEN VASCULAR-DISEASE | PULMONARY-FIBROSIS | SOCIETY | MANIFESTATIONS | Prognosis | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Idiopathic Pulmonary Fibrosis - immunology | Scleroderma, Systemic - immunology | Lung Diseases, Interstitial - immunology | Autoantibodies - immunology | Idiopathic Interstitial Pneumonias - physiopathology | Scleroderma, Systemic - physiopathology | Vital Capacity - physiology | Female | Aged | Idiopathic Pulmonary Fibrosis - physiopathology | Retrospective Studies | Lung Diseases, Interstitial - physiopathology | Idiopathic Interstitial Pneumonias - immunology | Complications and side effects | Care and treatment | Pulmonary fibrosis | Autoantibodies | Systemic scleroderma | Scleroderma (Disease) | Causes of | Physiological aspects | Diagnosis | Research | Pneumonia | Lung | Medical records | Arthritis | Sclerosis | Connective tissues | Computed tomography | Tomography | Scleroderma | Thickening | Lupus | Pulmonary arteries | Mortality | Lung diseases | Rheumatology | Patients | Medicine | Hospitals | Biopsy | Systemic sclerosis | Scab | Medical prognosis | Radiology | Diagnostic systems | Interferon | Females | Smoking | Index Medicus
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 6/2016, Volume 77, Issue 6, pp. 1245 - 1252
There is no established standard regimen for non-small cell lung cancer (NSCLC) patients with interstitial lung disease (ILD). For them, we performed a pilot... 
Medicine & Public Health | S-1 | Non-small cell lung cancer | Carboplatin | Oncology | Cancer Research | Pharmacology/Toxicology | Interstitial lung disease | Acute exacerbation | PLUS CARBOPLATIN | CHEMOTHERAPY | TRIAL | WEEKLY PACLITAXEL | ONCOLOGY | GASTRIC-CANCER | RANDOMIZED PHASE-III | PHARMACOLOGY & PHARMACY | IDIOPATHIC PULMONARY-FIBROSIS | JAPAN ONCOLOGY GROUP | ORAL FLUOROPYRIMIDINE | Lung Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Carboplatin - adverse effects | Carboplatin - therapeutic use | Female | Tegafur - adverse effects | Tegafur - therapeutic use | Kaplan-Meier Estimate | Carboplatin - administration & dosage | Oxonic Acid - administration & dosage | Lung Diseases, Interstitial - complications | Lung Diseases, Interstitial - drug therapy | Oxonic Acid - adverse effects | Lung Neoplasms - complications | Carcinoma, Non-Small-Cell Lung - complications | Disease-Free Survival | Oxonic Acid - therapeutic use | Pilot Projects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Tegafur - administration & dosage | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Drug Combinations | Antimitotic agents | Care and treatment | Chemotherapy | Lung diseases | Oncology, Experimental | Lung cancer, Small cell | Research | Lung cancer, Non-small cell | Antineoplastic agents | Cancer | Index Medicus
Journal Article
Internal medicine (Tokyo, Japan), ISSN 0918-2918, 06/2019, Volume 58, Issue 18, p. 2605
Objective Rapidly progressive interstitial lung disease (RP-ILD) with anti-melanoma differentiation-associated protein 5 (MDA5) antibody potentially presents... 
Medical personnel | Physicians | Lung | Lung diseases | Medical services | Melanoma | Antibodies | Medical records | Patients | Proteins | Consolidation | Computed tomography | Fatalities | Opacity | Differentiation | Alveoli
Journal Article
Internal medicine (Tokyo, Japan), ISSN 0918-2918, 06/2019, Volume 58, Issue 18, p. 2679
We herein report a 45-year-old woman with lung adenocarcinoma stage IV (cT4N3M1a). She was treated with pemetrexed (PEM) monotherapy following four cycles of... 
Adenocarcinoma | Medical personnel | Chest | Granuloma | Pneumonia | Signs and symptoms | Physicians | Lung | Lung diseases | Hypersensitivity | Medical services | Bronchus | Mimicry | Dyspnea | Computed tomography | Biopsy | Lymphocytes | Bronchoalveolar lavage | Paclitaxel | Carboplatin | Attenuation | Respiration | Alveoli | Alveolitis
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2017, Volume 7, Issue 1, pp. 10811 - 7
After the commercialization of nintedanib in Japan, a high incidence of hepatotoxicity resulting in treatment interruption was noted in idiopathic pulmonary... 
EFFICACY | INHIBITOR | SAFETY | MULTIDISCIPLINARY SCIENCES | Alanine | Statistical analysis | Pulmonary fibrosis | Lung diseases | Fibrosis | Alanine transaminase | Aspartate aminotransferase | Surface area | Hepatotoxicity | Risk factors | Index Medicus
Journal Article
Journal Article